# Rocky Mountain Tissue Bank – FDA Inspection, Feb 22, 2013

Source: https://www.keypedia.com/records/fda_inspections/rocky-mountain-tissue-bank/5fd402d9-4ea8-4b72-8d98-97537920f14a
Source feed: FDA_Inspections

> FDA inspection 823145 of Rocky Mountain Tissue Bank, February 22, 2013. Classification: Voluntary Action Indicated (VAI). 14 citations under 21 CFR part 1271. 6 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 823145
- Company Name: Rocky Mountain Tissue Bank
- Inspection Date: 2013-02-22
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Center: Biologics
- Office Name: Center for Biologics Evaluation and Research
- Citation Count: 14

## Related Documents

- FDA Inspection 1233237 - 2024-03-04
- FDA Inspection 1071051 - 2018-10-17
- [FDA Inspection 997992 - 2016-10-24](https://www.keypedia.com/records/fda_inspections/rocky-mountain-tissue-bank/60ff9dbd-00ec-43e4-b0f4-e26db833c2ca)
- FDA Inspection 900994 - 2014-10-22
- FDA Inspection 709950 - 2011-02-15

Company: https://www.keypedia.com/companies/rocky-mountain-tissue-bank/ec319162-df1d-4800-a6e4-a5dff5f3c202

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d